Lily Serge

Lily Serge is a strategic commercial leader with extensive experience across therapeutic areas and stages of the product lifecycle, including immunology, oncology, and renal therapeutic areas. Previously, they held roles at renowned companies, including Rosetta as a Manager and AstraZeneca as a Director of Tumor Strategy in the Oncology Business Unit. Currently, they serve as the Alliance Senior Director at AstraZeneca, leveraging their expertise in TPP development, patient journey mapping, and business case creation. Lily's background also includes market research at Lux Research, where they focused on renewable energy and advanced materials.